Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.

NCT01204671 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01204671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01204671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 4, 2010
Completion date
June 6, 2011
Enrollment
4,659 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

influenza